These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2755662)

  • 1. [Dynamics of visual function in glaucoma patients treated with various antiglaucoma preparations].
    Zhaboedov GD; Slavnova AV; Fedirko PA
    Oftalmol Zh; 1989; (2):69-72. PubMed ID: 2755662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study.
    O'Connor MA; Mooney DJ
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 6)():588-92. PubMed ID: 6385355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R; Agarwal HC; Rajashekar YL
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of local hypotensive therapy on ocular hemodynamics in patients with primary open-angle glaucoma].
    Bakshinskiĭ PP
    Vestn Oftalmol; 1999; 115(1):8-10. PubMed ID: 10207311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol and guanethidine plus adrenaline in combination in the treatment of chronic open angle glaucoma.
    Mills KB; Vogel R; Jacobs N
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 6)():621-4. PubMed ID: 3866411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pilaren in the therapy of open-angle glaucoma].
    Erichev VP; Maĭchuk IuF
    Vestn Oftalmol; 1988; 104(5):16-9. PubMed ID: 3222825
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative evaluation of timolol maleate and pilocarpine in the treatment of chronic open angle glaucoma.
    Dallas NL; Sponsel WE; Hobley AJ
    Eye (Lond); 1988; 2 ( Pt 3)():243-9. PubMed ID: 3042470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lang lecture 1986. The enigma of primary open-angle glaucoma.
    Smith RJ
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 6)():618-33. PubMed ID: 3310339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and socio-economic aspects of long term therapy of open angle glaucoma.
    Sood NN; Kumar H; Patil ND; Aggarwal AC; Sihota R
    Indian J Ophthalmol; 1991; 39(3):91-3. PubMed ID: 1841899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma].
    Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM
    Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
    Robin AL
    Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
    Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
    Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmic Surg Lasers; 1996 Sep; 27(9):806-9. PubMed ID: 8878205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.